Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ethel Gorender"'
Autor:
Juliana Passinho, Antonio F. Purificacao Junior, Renato Guedes Oliveira, Ethel Gorender, Renato Melaragno Waldir Beira, Kaito Alves Carvalho Laube, Gregori Manfroi, Roberta Rehder, Sidnei Epelman
Publikováno v:
Neurosurgery. 69:41-42
Publikováno v:
Neuro-Oncology
BACKGROUND Long-term survival in diffuse intrinsic pontine glioma is rare, and typically associated with atypical imaging and/or atypical clinical course. Although most patients harbor hotspot mutations in H3.1/3-K27M, a proportion of patients have a
Autor:
Sueli M. Cruz, Lourdes A. Marques, Sidnei Epelman, Ethel Gorender, Agnaldo Anelli, Artur Katz, Ricardo M. Oliveira
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 121:128-131
Chemotherapy with oxazaphosphorines, such as ifosfamide, is often limited by unacceptable urotoxicity. Without uroprotection hemorrhagic cystitis becomes dose-limiting. Mesna, a thiol compound, is a drug able to bind the toxic metabolites, forming no
Publikováno v:
Journal of Clinical Oncology. 33:10061-10061
10061 Background: DIPG are amongst the most challenging tumors to treat in childhood with no drug proven to be effective. Standard of care remains focal radiotherapy alone however, rapid disease pr...
Publikováno v:
Journal of Clinical Oncology. 31:10065-10065
10065 Background: Bacterial and invasive fungal infections remain a major contributor to treatment related morbidity and mortality in cancer patients. It has been published data of potential prevention; in immunocompromised hosts derive primarily fro
Autor:
Sidnei Epelman, Ethel Gorender, Priscila Meirelles, Renato Melaragno, Renato Guedes Oliveira, Annick Beaugrand
Publikováno v:
Journal of Clinical Oncology. 31:10057-10057
10057 Background: CYCLO and IFOS are two of the most active agents in childhood cancer. There is non-cross resistance between CYCLO and IFOS and they have dissimilar toxic side effects. In vitro, tumor model systems document that alkylator resistance